Quick Needle-Free test could spot long COVID

NCT ID NCT07343856

ENROLLING_BY_INVITATION Diagnosis Sponsor: Oncology Center,Ministry Of Heath,Uzbekistan Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new, non-invasive diagnostic method for long COVID. Researchers will use a single-session bioelectrical assessment to detect patterns linked to viral persistence in 50 adults with long COVID. The goal is to see if this approach can reliably identify ongoing viral antigens without needles or drugs.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could provide a quick, non-invasive diagnostic tool for long COVID, helping identify persistent viral antigens.

What could go wrong

This is a very small, early-stage diagnostic study (50 participants) with no treatment. The method is experimental and may not prove reliable or generalizable.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG COVID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

long COVID-19 primary dysautonomia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

LONG COVID POST ACUTE SEQUELAE OF SARS COV 2 INFECTION

Contacts and locations

Show contact details

Locations

Research Institute of Virology

Tashkent, 100194, Uzbekistan